Stool DNA Testing For Colon Cancer Dec 14, 2006
Mount Sinai School of Medicine and EXACT Sciences Corporation have announced the publication of results from a prospective, multi-center study of stool DNA testing. The study found that the test demonstrated an 88% sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer's location in the colon. (Science Daily)
Semi-Annual Changes to the NASDAQ Biotechnology Index May 15, 2005
As a result of the re-ranking, Avigen Inc (Nasdaq: ), EXACT Sciences Corporation (Nasdaq: ), Forbes Medi-Tech Inc. (Nasdaq: ), Gen-Probe Incorporated (Nasdaq: ), and Maxim Pharmaceuticals, Inc. (Nasdaq: ) will be removed from the Index. The NASDAQ Biotechnology Index is the basis for the iShares Nasdaq Biotechnology Index(SM) Fund (Amex: ), which seeks investment results that generally correspond to the price and yield performance of the NASDAQ Biotechnology Index before fees and expenses. (PR Newswire)
EXACT Sciences Announces First Quarter 2005 Results Apr 26, 2005
Source: EXACT Sciences Corporation ... --(BUSINESS WIRE)--April 25, 2005--EXACT Sciences Corporation (NASDAQ: - ) today announced results for the first quarter ending March 31, 2005 ... About EXACT Sciences Corporation. (Yahoo Finance -- Biotechnology & Drugs)